Loading WAT detail
Loading ticker data...
Loading WAT detail
Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe.
It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. Its MS technology instruments are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. The company offers thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer good, and healthcare products, as well as for life science research. Its products are used by life science, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications.
Waters Corporation was founded in 1958 and is headquartered in Milford, Massachusetts.
Chart data unavailable
Waters Corporation (NYSE:WAT) shares are up on Wednesday as the company announced FDA clearance for its Onclarity HPV Self-Collection Kit, a significant step in expanding access to cervical cancer screening.
FDA-approved BD Onclarity™ HPV Assay is the most comprehensive screening tool for HPV in the U.S.1,4 with extended genotyping and end-to-end automated lab workflows. At-home self-collection reduces significant barriers for unscreened or under-screened individuals who make up approximately 60% of cervical cancer cases.3 Waters is establishing partnerships to enable broader nationwide access to the Onclarity™ HPV Self-Collection Kit for patients and prescribers to reduce cervical cancer risk.
We bought four “new” holdings in the quarter. Two of the four — Blackstone and Otis — we have owned before. In IT, we exited Oracle and trimmed Broadcom. Our five-year investment in Oracle proved highly profitable as the company transitioned its business model from licensing to software-as-a-service. On the semiconductor side, we modestly reduced our position in Broadcom to fund our new investment in Taiwan Semiconductor.
Aberdeen Group plc decreased its holdings in shares of Waters Corporation (NYSE: WAT) by 3.6% during the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 73,863 shares of the medical instruments supplier's stock after selling 2,721 shares during the quarter. Aberdeen Group
ADB International Group (OTCMKTS:EQUR - Get Free Report) and Waters (NYSE: WAT - Get Free Report) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their risk, valuation, institutional ownership, earnings, dividends, profitability and analyst recommendations. Valuation and Earnings This table compares ADB International
Waters (NYSE: WAT - Get Free Report) and Vicarious Surgical (NYSE: RBOT - Get Free Report) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, earnings, profitability, institutional ownership, valuation and risk. Insider and Institutional Ownership 94.0% of Waters shares are
MILFORD, Mass., March 18, 2026 /PRNewswire/ -- Waters Corporation (NYSE: WAT) (the "Company" or "Waters") today announced that it has priced an offering (the "Offering") of $3.5 billion aggregate principal amount of the following senior notes issued by its subsidiary, Augusta SpinCo Corporation ("Augusta"): $650 million aggregate principal amount of 4.321% Senior Notes due 2027 at the issue price of 100.000% of their principal amount; $600 million aggregate principal amount of 4.398% Senior Notes due 2029 at the issue price of 100.000% of their principal amount; $750 million aggregate principal amount of 4.656% Senior Notes due 2031 at the issue price of 100.000% of their principal amount; $750 million aggregate principal amount of 4.945% Senior Notes due 2033 at the issue price of 100.000% of their principal amount; and $750 million aggregate principal amount of 5.245% Senior Notes due 2036 at the issue price of 100.000% of their principal amount (collectively, the "Notes").
SEATTLE--(BUSINESS WIRE)--Redfin economists estimate annual housing inventory could increase by 6%-12% in markets where home sellers are given the flexibility to test out pricing strategies via ‘Private Exclusive' and ‘Coming Soon' listings (i.e., phased marketing) before formally putting their homes on the market. That's according to a new report from Redfin, the real estate brokerage powered by Rocket. “Every home is unique,” said Redfin Senior Economist Asad Khan. “That makes it challenging.
Waters (WAT) reported earnings 30 days ago. What's next for the stock?
News Summary: Reduces standard testing times by 80%.1 Delivers an industry-leading 25,000 data points per second, detecting transient material behaviors previously invisible to measurement. 2 Operates with fewer calibrations and superior atmosphere and temperature control.
Waters (WAT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Waters Corporation (WAT) Presents at TD Cowen 46th Annual Health Care Conference Transcript
Artisan Partners Limited Partnership decreased its position in shares of Waters Corporation (NYSE: WAT) by 9.0% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 354,899 shares of the medical instruments supplier's stock after selling 34,925 shares during the period. Artisan
After losing some value lately, a hammer chart pattern has been formed for Waters (WAT), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.
Andra AP fonden grew its holdings in shares of Waters Corporation (NYSE: WAT) by 1,044.8% in the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 116,140 shares of the medical instruments supplier's stock after purchasing an additional 105,995 shares during the quarter. Andra
